EFFICACY AND SAFETY OF NIPOCALIMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: TOPLINE RESULTS FROM THE DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE 3 VIVACITY-MG3 STUDY

被引：0
|
作者：
Vu, Tuan
Antozzi, Carlo
Ramchandren, Sindhu
Nowak, Richard J.
Farmakidis, Constantine
Bril, Vera
De Bleecker, Jan
Yang, Huan
Minks, Eduard
Park, Jin-Sung
Grudniak, Mariusz
Smilowski, Marek
Sevilla, Teresa
Hoffmann, Sarah
Sivakumar, Kumaraswamy
Youssef, Eriene
Sanga, Panna
Karcher, Keith
Zhu, Yaowei
Ling, Leona
Sun, Hong
机构：
来源：
MUSCLE & NERVE | 2024年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MG43
引用
收藏
页码：655 / 655
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study
    Antozzi, Carlo
    Vu, Tuan
    Ramchandren, Sindhu
    Nowak, Richard J.
    Farmakidis, Constantine
    Bril, Vera
    De Bleecker, Jan
    Yang, Huan
    Minks, Eduard
    Park, Jin-Sung
    Grudniak, Mariusz
    Smilowski, Marek
    Sevilla, Teresa
    Hoffmann, Sarah
    Sivakumar, Kumaraswamy
    Suzuki, Yasushi
    Youssef, Eriene
    Sanga, Panna
    Karcher, Keith
    Zhu, Yaowei
    Sheehan, John J.
    Sun, Hong
    LANCET NEUROLOGY, 2025, 24 (02): : 105 - 116
  • [2] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 3 STUDY OF INEBILIZUMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS (MINT): TOPLINE EFFICACY AND SAFETY FINDINGS
    Nowak, Richard
    Utsugisawa, Kimiaki
    Benatar, Michael
    Ciafaloni, Emma
    Leite, M. Isabel
    Vissing, John
    Tang, Fengming
    Wu, Yanping
    Rojavin, Mikhail
    Rampal, Nishi
    Howard, James, Jr.
    MUSCLE & NERVE, 2024, 70 (03) : 653 - 654
  • [3] Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis
    Guptill, Jeffrey
    Antozzi, Carlo
    Bril, Vera
    Gamez, Josep
    Meuth, Sven G.
    Blanco, Jose Luis Munoz
    Nowak, Richard J.
    Quan, Dianna
    Sevilla, Teresa
    Szczudlik, Andrzej
    Hegarty, Brooke
    Jouvin, Marie-Helene
    Jin, Jim
    Arroyo, Santiago
    NEUROLOGY, 2021, 96 (15)
  • [4] EFFICACY AND SAFETY OF ROZANOLIXIZUMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY (MYCARING)
    Bril, Vera
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali A.
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vissing, John
    Vu, Tuan
    Boehnlein, Marion
    Woltering, Franz
    Bozorg, Ali
    Gayfieva, Maryam
    Kaminski, Henry
    MUSCLE & NERVE, 2022, 65 : S35 - S35
  • [5] LONG-TERM SAFETY AND EFFICACY OF NIPOCALIMAB IN GENERALIZED MYASTHENIA GRAVIS: VIVACITY-MG3 OPEN-LABEL INTERIM ANALYSIS
    Antozzi, Carlo
    Vu, Tuan
    Ramchandren, Sindhu
    Nowak, Richard J.
    Farmakidis, Constantine
    Bril, Vera
    De Bleecker, Jan
    Yang, Huan
    Minks, Eduard
    Park, Jin-Sung
    Grudniak, Mariusz
    Smilowski, Marek
    Sevilla, Teresa
    Hoffmann, Sarah
    Sivakumar, Kumaraswamy
    MUSCLE & NERVE, 2024, 70 (03) : 674 - 675
  • [6] Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
    Howard Jr, James F.
    Bresch, Saskia
    Genge, Angela
    Hewamadduma, Channa
    Hinton, John
    Hussain, Yessar
    Juntas-Morales, Raul
    Kaminski, Henry J.
    Maniaol, Angelina
    Mantegazza, Renato
    Masuda, Masayuki
    Sivakumar, Kumaraswamy
    Smilowski, Marek
    Utsugisawa, Kimiaki
    Vu, Tuan
    Weiss, Michael
    Zajda, Malgorzata
    Boroojerdi, Babak
    Brock, Melissa
    de la Borderie, Guillemette
    Duda, Petra W.
    Lowcock, Romana
    Vanderkelen, Mark
    Leite, M. Isabel
    LANCET NEUROLOGY, 2023, 22 (05): : 395 - 406
  • [7] VIVACITY-MG: A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, EFFICACY, PHARMACO-KINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF NIPOCALIMAB ADMINISTERED TO ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
    Antozzi, Carlo
    Guptill, Jeffrey
    Bril, Vera
    Gamez, Josep
    Meuth, Sven G.
    Blanco, Jose L. M.
    Nowak, Richard J.
    Quan, Dianna
    Sevilla, Teresa
    Szczudlik, Andrzej
    Hegarty, Brooke
    Jouvin, Marie-Helene
    Jin, Jim
    Arroyo, Santiago
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 498 - 498
  • [8] OUTCOMES FROM RAISE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ZILUCOPLAN IN GENERALIZED MYASTHENIA GRAVIS
    Howard, James F., Jr.
    Genge, Angela
    Hussain, Yessar
    Kaminski, Henry J.
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vu, Tuan
    Brock, Melissa
    Boroojerdi, Babak
    Vanderkelen, Mark
    de la Borderie, Guillemette
    Duda, PetraW
    Leite, M. Isabel
    MUSCLE & NERVE, 2022, 65 : S34 - S35
  • [9] ECULIZUMAB SAFETY AND EFFICACY IN REFRACTORY MYASTHENIA GRAVIS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY
    Howard, J.
    Utsugisawa, K.
    Beneatr, M.
    Murai, H.
    Barohn, R.
    Sendra, I. I.
    Pons, C. C.
    Jacob, S.
    Cutter, Gary
    Vissing, J.
    Burns, T.
    Bleecker, J. D.
    Kissel, J.
    Muppidi, S.
    Nowak, R.
    O'Brien, F.
    Wang, J.
    Vu, T.
    Mantegazza, R.
    MUSCLE & NERVE, 2016, 54 (03) : 645 - 645
  • [10] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF TELITACICEPT IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Vu, Tuan
    Cui, Xiaoming
    Fang, Jianmin
    Zuraw, Qing
    MUSCLE & NERVE, 2024, 70 (03) : 612 - 612
12345